Search for: "JANSSEN PHARMACEUTICALS, INC. "
Results 21 - 40
of 226
Sorted by Relevance
|
Sort by Date
4 Nov 2013, 3:04 am
On November 4, the Department of Justice announced that Johnson & Johnson and its subsidiaries, Janssen Pharmaceuticals, Inc., and Scios, Inc., had agreed to pay $2.2 billion to resolve claims originally brought by whistleblowers that the company promoted its drugs Risperdal, Invega, and Natrecor for unapproved (off-label) uses. [read post]
17 Jun 2012, 9:55 pm
Searle, LLC • Defendants: Hetero Drugs, Ltd., Unit III; Invagen Pharmaceuticals, Inc. [read post]
31 Aug 2016, 1:31 pm
Janssen Pharmaceuticals, Inc. on May 11th, and ruled that Janssen neglected to make an effort to warn physicians of the risks regarding Topamax. [read post]
31 Aug 2016, 1:31 pm
Janssen Pharmaceuticals, Inc. on May 11th, and ruled that Janssen neglected to make an effort to warn physicians of the risks regarding Topamax. [read post]
10 Jul 2014, 10:00 pm
Janssen Biotech, Inc. [read post]
26 Sep 2017, 12:46 pm
About a dozen pharmaceutical companies, including Purdue Pharma L.P., Janssen Pharmaceuticals Inc. and Allergan PLC, filed a brief Friday saying they’ve complied with the U.S. [read post]
12 Sep 2012, 6:14 pm
IPNews® - Johnson & Johnson unit Janssen Pharmaceuticals Inc. won a major patent infringement victory Tuesday when a New Jersey federal judge held that its patent for the popular birth control drug Ortho Tri-Cyclen Lo is valid. [read post]
8 Dec 2016, 12:44 pm
The United States Judicial Panel on Multidistrict Litigation (“JPML”) ordered on Wednesday that 55 active suits against the pharmaceutical company Janssen Pharmaceuticals and its parent corporation Johnson & Johnson, be consolidated in the District of New Jersey under Judge Brian R. [read post]
7 Dec 2017, 3:09 pm
On Tuesday, a jury entered a verdict of $27.8 million against Johnson & Johnson’s Janssen Pharmaceuticals, Inc. and Bayer AG’s Bayer Pharmaceuticals Inc. in the first state court trial out of the Philadelphia County Court of Common Pleas’ mass tort program consolidating Xarelto-related injury lawsuits. [read post]
23 Feb 2010, 9:01 pm
By Suresh Pillai -- Lupin Claims Tri-Cyclen® Patent Invalid Lupin Pharmaceuticals Inc. has filed counterclaims in its suit with Ortho-McNeil-Janssen Pharmaceuticals Inc., alleging that Ortho's patent covering its Tri-Cyclen® Lo contraceptive, U.S. [read post]
3 Oct 2011, 9:28 pm
Ortho-McNeil-Janssen Pharmaceuticals, Inc., No. 11-2070 (7th Cir. [read post]
10 Dec 2015, 8:00 pm
The petition of the day is: Ortho-McNeil-Janssen Pharmaceuticals Inc. v. [read post]
28 Apr 2024, 8:18 pm
Cir. 2024)Janssen Pharmaceuticals, Inc. v. [read post]
16 Mar 2015, 11:54 am
Janssen Pharmaceuticals, Inc. at this link. [read post]
11 Jan 2016, 7:32 am
The justices on Monday let stand a lower court ruling that said Janssen Pharmaceuticals, Inc. should pay the penalties for violations of South Carolina law. [read post]
24 Feb 2020, 8:46 pm
Wholesaler acquires Remicade pursuant to a Distribution Agreement with JOM Pharmaceutical Services, Inc. [read post]
25 Jan 2010, 8:42 pm
The United States filed a qui tam or False Claims Act complaint against Johnson & Johnson (J&J) and its subsidiary companies Johnson & Johnson Health Care Systems Inc. and Ortho-McNeil-Janssen Pharmaceuticals Inc. [read post]
11 Feb 2014, 2:55 am
Janssen Pharm., Inc., No. 12-2132, 2014 U.S. [read post]
11 Feb 2014, 2:55 am
Janssen Pharm., Inc., No. 12-2132, 2014 U.S. [read post]
27 May 2024, 9:26 pm
Cir. 2024)Janssen Pharmaceuticals, Inc. v. [read post]
